Ionis Pharmaceuticals(US:IONS) Seeking Alphaยท2024-10-23 20:25Core Insights - Ionis Pharmaceuticals (NASDAQ: IONS) is being considered as a potential "strong buy" opportunity, particularly following the release of its Q1 earnings in May [1] Company Overview - Ionis is based in Carlsbad, California, and specializes in the development of antisense oligonucleotide therapeutics [1] - The company has been covered multiple times by analysts, indicating ongoing interest and analysis in its performance and potential [1] Investment Analysis - The investment group Haggerston BioHealth provides insights for both novice and experienced biotech investors, including catalysts to watch for, buy and sell ratings, and forecasts for product sales across major pharmaceutical companies [1] - Detailed reports on over 1,000 companies have been compiled, showcasing the depth of analysis available for investors [1]